Strategic investments in non-communicable diseases (NCD) research in Africa: The GSK Africa NCD Open Lab

Cardiovascular Journal of Africa

Volumn 26, Issue 2, 2015, Pages S15-S17

  Hall, Matthew D ^a   Dufton, Ann M ^a   Katso, Roy M ^a   Gatsi, Sally A ^a   Williams, Pauline M ^a   Strange, Michael E ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Africa; Capacity building; Collaboration; Non communicable diseases; Open innovation; Training

Indexed keywords

AFRICA; AFRICAN; ARTICLE; CAUSE OF DEATH; CLINICAL LABORATORY; DEVELOPING COUNTRY; GOVERNMENT; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL EDUCATION; MEDICAL RESEARCH; MORTALITY; NON COMMUNICABLE DISEASE; ORGANIZATION; TRAINING; CHRONIC DISEASE; COMMUNICABLE DISEASES; COOPERATION; ECONOMICS; INTERNATIONAL COOPERATION; INVESTMENT; LABORATORY;

AFRICA; CHRONIC DISEASE; COMMUNICABLE DISEASES; COOPERATIVE BEHAVIOR; HUMANS; INTERNATIONAL COOPERATION; INVESTMENTS; LABORATORIES;

EID: 84930033557     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2015-042     Document Type: Article

References (10)

1. 65th World Health Assembly closes with new global health measures. http://www.who.int/mediacentre/news/releases/2012/wha65-closes-20120526/en/index.html. Accessed 12 December 2014.
2. A major victory at the World Health Assembly for NCDs. http://ncdalliance.org/news/major-victory-world-health-assembly-ncds. Accessed 12 December 2014.
3. Alwan A. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization, 2011. http://www.who.int/nmh/publications/ncd-report2010/en/. Accessed 12 December 2014.
4. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet 2010; 375(9733): 2254-2266. DOI: 10.1016/ S0140-6736(10)60550-8.
5. Dillon DG, Gurdasani D, Riha J, et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol 2013; 42(6): 1754-1771. DOI: 10.1093/ije/dyt198.
6. Witty A. New strategies for innovation in global health: a pharmaceutical industry perspective. Health Affairs 2011; 30(1): 118-126. DOI: 10.1377/hlthaff.2010.0933.
7. Tres Cantos Open Lab Foundation. http://www.openlabfoundation.org. Accessed 12 December 2014.
8. GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth. http://www.gsk.com/en-gb/media/press-releases/2014/gsk-announces-new-strategicinvestments-in-africa-to-increase-access-to-medicines-build-capacityand-deliver-sustainable-growth/. Accessed 12 December 2014.
9. GSK Pharmaceuticals: our pharmaceuticals business develops and makes a broad range of medicines to treat both acute and chronic diseases. http://www.gsk.com/en-gb/about-us/what-we-do/pharmaceuticals/. Accessed 11 March 2015.
10. GSK and Save the Children form unique partnership to save the lives of one million children. http://www.gsk.com/en-gb/media/pressreleases/2013/gsk-and-save-the-children-form-unique-partnership-tosave-the-lives-of-one-million-children/. Accessed 12 December 2014.